Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Structural Joints: Cartilaginous Joints01:17

Structural Joints: Cartilaginous Joints

As the name indicates, at a cartilaginous joint, the adjacent bones are united by cartilage, a tough but flexible type of connective tissue. Unlike synovial joints, these types of joints lack a joint cavity and involve bones joined together by either hyaline cartilage or fibrocartilage.
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary or...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Targeting fibroblast-like synoviocytes with CDK4/6 inhibitors as a novel, non-immunosuppressive treatment strategy for rheumatoid arthritis.

Clinical and experimental rheumatology·2025
Same author

Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging.

Therapeutic advances in musculoskeletal disease·2024
Same author

Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease.

The Journal of allergy and clinical immunology·2023
Same author

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.

JAMA dermatology·2021
Same author

Transcriptional regulator BOB.1: Molecular mechanisms and emerging role in chronic inflammation and autoimmunity.

Autoimmunity reviews·2021
Same author

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?

Frontiers in immunology·2021

Video Experimental Relacionado

Updated: May 31, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

La espondiloartritis es una enfermedad de la espondiloartritis.

Maxime Dougados1, Dominique Baeten

  • 1Paris-Descartes University, Medicine Faculty, UPRES EA 4058, AP-HP, Cochin Hospital, Department of Rheumatology B, Paris, France. m.doug@cch.aphp.fr

Lancet (London, England)
|June 21, 2011
PubMed
Resumen
Este resumen es generado por máquina.

La espondiloartritis abarca varias afecciones relacionadas, con avances recientes que mejoran la clasificación y la comprensión de la inflamación. La investigación futura tiene como objetivo el diagnóstico temprano y los tratamientos para detener el daño estructural y lograr la remisión a largo plazo.

Más Videos Relacionados

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
04:47

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

Published on: October 27, 2023

Videos de Experimentos Relacionados

Last Updated: May 31, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
04:47

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

Published on: October 27, 2023

Área de la Ciencia:

  • Reumatología Reumatología.
  • Inmunología Inmunología.
  • Genética La genética.

Sus antecedentes:

  • La espondiloartritis es un espectro de trastornos relacionados que incluye artritis psoriásica, artritis relacionada con enfermedades inflamatorias intestinales, artritis reactiva, artritis idiopática juvenil y espondilitis anquilosante.
  • El progreso significativo en la última década ha mejorado el reconocimiento, la clasificación y la comprensión de los mecanismos genéticos y fisiopatológicos subyacentes a la espondiloartritis.
  • Los avances en los resultados clínicos e imágenes facilitan la evaluación de las intervenciones terapéuticas.

Objetivo del estudio:

  • Revisar la comprensión actual de la espondiloartritis, incluida su clasificación y los mecanismos subyacentes.
  • Evaluar el impacto de los avances terapéuticos recientes, en particular los bloqueadores del factor de necrosis tumoral.
  • Identificar los desafíos clave y las direcciones futuras para el manejo de la espondiloartritis.

Principales métodos:

  • Revisión de la literatura de los avances recientes en la investigación de la espondiloartritis.
  • Análisis de las modalidades terapéuticas actuales y su eficacia.
  • Identificación de las necesidades no satisfechas y las futuras prioridades de investigación.

Principales resultados:

  • Los bloqueadores del factor de necrosis tumoral representan un gran avance terapéutico.
  • Las funciones precisas de la fisioterapia, los medicamentos antiinflamatorios no esteroideos y otros tratamientos biológicos requieren una mayor aclaración.
  • Se ha avanzado en la comprensión de los mecanismos de la enfermedad, la inflamación y el daño tisular.

Conclusiones:

  • Las técnicas de diagnóstico precoz son cruciales para una gestión eficaz.
  • Las estrategias terapéuticas deben centrarse en la modulación del daño estructural.
  • El objetivo final es inducir una remisión a largo plazo y sin medicamentos en pacientes con espondiloartritis.